Immunization of liver and renal transplant recipients: A seroepidemiological and sociodemographic survey

Transplant Infectious Disease

Volumn 11, Issue 6, 2009, Pages 507-512

  Chesi, C ^a   Gunther M ^a   Huzly, D ^b   Neuhaus, R ^a   Reinke, P ^a   Engelmann, H B ^c   Mockenhaupt, F P ^a   Bienzle, U ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c GLAXOSMITHKLINE   (Germany)

Author keywords

Immunization; Liver transplant; Renal transplant; Seroprotection; Survey; Transplantation; Vaccination

Indexed keywords

DIPHTHERIA VACCINE; HEPATITIS A VACCINE; HEPATITIS B VACCINE; PNEUMOCOCCUS VACCINE; TETANUS TOXOID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIPHTHERIA; FEMALE; GERMANY; GRAFT RECIPIENT; HEALTH SURVEY; HEPATITIS A; HEPATITIS B; HUMAN; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PASSIVE IMMUNIZATION; PNEUMOCOCCAL INFECTION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; SOCIAL STATUS; TETANUS;

ADOLESCENT; ADULT; AGED; ANTIBODIES, BACTERIAL; ANTIBODIES, VIRAL; BACTERIAL VACCINES; FEMALE; GERMANY; HEALTH SURVEYS; HUMANS; IMMUNIZATION; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; TRANSPLANTATION IMMUNOLOGY; VACCINATION; VIRAL VACCINES; YOUNG ADULT;

EID: 71149110997     PISSN: 13982273     EISSN: 13993062     Source Type: Journal    
DOI: 10.1111/j.1399-3062.2009.00436.x     Document Type: Article

References (32)

1. Cutts FT. Advances and challenges for the expanded programme on immunization. Br Med Bull 1998 54 (2) : 445 461.
2. Peltola H, Heinonen OP, Valle M, et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994 331 (21) : 1397 1402.
3. Centers for Disease Control and Prevention (CDC). Update: global measles control and mortality reduction worldwide, 1991-2001. Morb Mortal Wkly Rep 2003 52 (20) : 471 475.
4. Centers for Disease Control and Prevention (CDC). Progress toward interruption of wild poliovirus transmission worldwide, January 2004-March 2005. Morb Mortal Wkly Rep 2005 54 (16) : 408 412.
5. Patel R, Paya CV. Infections in solid-organ transplant recipients. Clin Microbiol Rev 1997 10 (1) : 86 124.
6. Stark K, Günther M, Schönfeld C, Tullius SG, Bienzle U. Immunisation in solid-organ transplant recipients. Lancet 2002 359 (9310) : 957 965.
7. Huzly D, Neifer S, Reinke P, et al. Routine immunizations in adult renal transplant recipients. Transplantation 1997 63 (6) : 839 845.
8. Burbach G, Bienzle U, Stark K, et al. Influenza vaccination in liver transplant recipients. Transplantation 1999 67 (5) : 753 755.
9. Günther M, Stark K, Neuhaus R, Reinke P, Schröder K, Bienzle U. Rapid decline of antibodies after hepatitis A immunisation in liver and renal transplant recipients. Transplantation 2001 71 (3) : 477 479.
10. Duchini A, Gross JA, Karpen S, Pockros PJ. Vaccination for adult solid organ transplant recipients: current recommendations and protocols. Clin Microbiol Rev 2003 16 (3) : 357 364.
11. Kotton CN, Ryan ET, Fishman JA. Prevention of infection in adult travelers after solid organ transplantation. Am J Transplant 2005 5 (1) : 8 14.
12. Zimmerman RK, Santibanez TA, Fine MJ, et al. Barriers and facilitators of pneumococcal vaccination among elderly. Vaccine 2003 21 (13-14) : 1510 1517.
13. Naumann P, Hagedorn H-J, Paatz R. Diphtherie-Immunität und ihre epidemiologische Bedeutung. Dtsch Med Wochenschr 1983 108 (28-29) : 1090 1096.
14. Fujiyama S, Odoh K, Kuramoto I, Mizuno K, Tsurusaki R, Sato T. Current seroepidemiological status of hepatitis A with a comparison of antibody titers after infection and vaccination. J Hepatol 1994 21 (4) : 641 645.
15. Szmuness W, Stevens CE, Zang EA, Harley EJ, Kellner A. A controlled clinical trial of the efficacy of hepatitis B vaccine: a final report. Hepatology 1981 1 (5) : 377 385. (Pubitemid 12218155)
16. Avery RK, Ljungman P. Prophylactic measures in the solid-organ recipient before transplantation. Clin Infect Dis 2001 33 (Suppl 1) : S15 S21.
17. Molrine DC, Hibberd PL. Vaccines for transplant recipients. Infect Dis Clin North Am 2001 15 (1) : 273 305.
18. Ballout A, Goffin E, Yombi JC, Vandercam B. Vaccinations for adult solid organ transplant recipient: current recommendations. Transplant Proc 2005 37 (6) : 2826 2827.
19. ACIP. Recommendations of the Advisory Committee on Immunization Practices (ACIP): use of vaccines and immune globulins for persons with altered immunocompetence. Morb Mortal Wkly Rep 1993 42 (RR-4) : 1 18.
20. ACIP. General recommendations on immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). Morb Mortal Wkly Rep 1994 43 (RR-1) : 1 38.
21. STIKO. Impfempfehlungen der Ständigen Impfkommission (STIKO) am Robert Koch-Institut. Epidemiol Bull 2005 31 : 273 276.
22. STIKO. Hinweise zu Impfungen für Patienten mit Immundefizienz. Epidemiol Bull 2005 39 : 353 364.
23. Anonymous. Guidelines for vaccination of solid organ transplant candidates and recipients. Am J Transplant 2004 4 (Suppl 10) : 160 163.
24. Batiuk TD, Bodziak KA, Goldman M. Infectious disease prophylaxis in renal transplant patients: a survey of US transplant centers. Clin Transplant 2002 16 (1) : 1 8.
25. Zeldin GA, Maygers J, Klein A, Thuluvath PJ. Vaccination, screening for malignancy, and health maintenance of the liver transplant recipient. J Clin Gastroenterol 2001 32 (2) : 148 150.
26. Miller ER, Alter MJ, Tokars JI. Protective effect of hepatitis B vaccine in chronic hemodialysis patients. Am J Kidney Dis 1999 33 (2) : 356 360.
27. Keeffe EB. Vaccination against hepatitis A and B in chronic liver disease. Viral Hepat Rev 1999 5 : 77 88.
28. Krüger S, Müller-Steinhardt M, Kirchner H, Kreft B. A 5-year follow-up on antibody response after diphtheria and tetanus vaccination in hemodialysis patients. Am J Kidney Dis 2001 38 (6) : 1264 1270.
29. Stark K, Günther M, Neuhaus R, et al. Immunogenicity and safety of hepatitis A vaccine in liver and renal transplant recipients. J Infect Dis 1999 180 (6) : 2014 2017.
30. Vilchez RA, McCurry K, Dauber J, et al. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002 2 (3) : 287 291.
31. Kimball P, Verbeke S, Flattery M, Rhodes C, Tolman D. Influenza vaccination does not promote cellular or humoral activation among heart transplant recipients. Transplantation 2000 69 (11) : 2449 2451.
32. Grekas D, Alivanis P, Kiriazopoulou V, Sioulis A, Derveniotis V, Tourkantonis A. Influenza vaccination in renal transplant patients is safe and serologically effective. Int J Clin Pharmacol Ther Toxicol 1993 31 (11) : 353 356.